Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

High-risk prostate cancer patients who undergo a combination of hormonal therapy, radioactive seed implant (also called brachytherapy) and external beam radiation therapy are shown to have an increased chance of cancer cure

29 Jul 2004

Further evidence about how estrogen helps activate breast cancer

A UC Irvine researcher has found a novel tumor- suppressor function for a gene that, when mutated, often triggers breast cancer in women.

29 Jul 2004

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

New research by Mieke Kriege at the Department of Medical Oncology, Rotterdam Family Cancer Clinic suggests that women with a history of cancer in their family are better off having MRI scans instead of mammogram's.

28 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Prostate cancer is much more likely to be aggressive if a key protein called Stat5 is found activated and in abundance in the cancer cells, report researchers from Georgetown University's Lombardi Comprehensive Cancer Center.

15 Jul 2004

Research may help predict risk for prostate cancer based on gene expression patterns

According to a study published in the July 15 issue of the Journal of Clinical Oncology, genes expressed in benign tissue adjacent to prostate cancer tissue are much more similar to those expressed in prostate cancer tissue than previously thought.

15 Jul 2004

Today's prostate cancer treatments are more aggressive and successful

In recent years, doctors have become more willing to treat prostate cancer more aggressively with radiation therapy, and as a result, more patients are being cured of their cancer

15 Jul 2004

Educating patients can help limit side effects of chemotherapy and radiation

A new study finds patients about to undergo chemotherapy or radiation expect a high number of side effects, and that age, gender, educational background, and the type of cancer all influence how many side effects a patient expects.

12 Jul 2004

British people should get out in the sun and not cover up for health reasons

British health is being put at risk by government policy that discourages sunbathing and promotes use of sunblock products. The cost of disease caused by insufficient exposure to sunlight and consequent deficiency of vitamin D is estimated to be billions of pounds per year in Britain.

5 Jul 2004

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

The four most common cancers - breast, lung, colorectal and prostate - accounted for over half of the 225,000 new cases of malignant cancer (excluding non-melanoma skin cancer) registered in England in 2001.

30 Jun 2004

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

As many prostate-cancer survivors have discovered, the lifesaving benefits of surgery, radiation and hormone therapy can come with a cost.

29 Jun 2004

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

More than 1 million American have prostate cancer, the leading non-skin cancer in men in the United States. Last year alone some 220,000 new prostate cancer cases were reported, and 28,900 men died of it.

25 Jun 2004

There are 9.8 million cancer survivors in the United States

A cancer survivor is defined as anyone who has been diagnosed with cancer, from the time of diagnosis through the balance of his or her life. The findings are published in the June 25 issue of CDC's Morbidity and Mortality Weekly Report, "Cancer Survivorship - United States, 1971 - 2001."

24 Jun 2004

Prostate and kidney cancer can be detected in urine

Bladder cancer is the fourth most common male cancer in the Western world. There will be more than 44,6000 new cases of bladder cancer diagnosed in U.S. men this year and more than 15,600 new cases diagnosed in women As many as 25 percent of these cancers are diagnosed after the disease is advanced, leading to a poor prognosis.

23 Jun 2004

More precise and less invasive procedure for prostate cancer detection

Work by a University of Queensland researcher will make the trip to the doctor for a prostate cancer check a lot more appealing for men.

17 Jun 2004

NICE guides new treatments for prostate cancer, drugs misuse, osteoporosis and heart failure

New treatments for prostate cancer, drugs misuse, osteoporosis and heart failure are being referred to the National Institute for Clinical Excellence (NICE), Lord Warner announced today.

16 Jun 2004

New operating room with 3-dimensional technology that takes modern robotic surgery to new levels

Surgical teams are now performing robotic surgery for prostate cancer with enhanced efficiency, comfort and communication using this unique technology.

15 Jun 2004

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

According to background information provided by the authors, "Ten years have passed since Congress responded to concerns about unequal access to clinical trials and enacted the National Institutes of Health (NIH) Revitalization Act, which encouraged representation of women and minority patients in NIH-sponsored research.

14 Jun 2004

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Johns Hopkins Kimmel Cancer Center clinicians were among those at leading institutions that have completed a three-year international study showing that docetaxel, a drug made from yew tree needles, decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy.

11 Jun 2004

Prostate cancer immunotherapy vaccine hits clinical trials

Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.

10 Jun 2004

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Combination of hormonal therapy, radioactive seed implant and external beam radiation therapy increases chance of cancer cure

Further evidence about how estrogen helps activate breast cancer

Women with a history of cancer in their family are better off having MRI scans instead of mammograms

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Stat5 protein is particularly plentiful in high histological grade human prostate cancer

Research may help predict risk for prostate cancer based on gene expression patterns

Today's prostate cancer treatments are more aggressive and successful

Educating patients can help limit side effects of chemotherapy and radiation

British people should get out in the sun and not cover up for health reasons

Four most common cancers accounted for over half of the 225,000 new cases of malignant cancer registered in England in 2001

Men can live a long time after treatment for prostate cancer, and they deserve to have a good quality of life

New study could bring hope to men who don't respond well to hormone therapy for prostate cancer

There are 9.8 million cancer survivors in the United States

Prostate and kidney cancer can be detected in urine

More precise and less invasive procedure for prostate cancer detection

NICE guides new treatments for prostate cancer, drugs misuse, osteoporosis and heart failure

New operating room with 3-dimensional technology that takes modern robotic surgery to new levels

Racial and ethnic minorities, women, and the elderly were less likely to enroll in cancer clinical trials than whites, men, and younger patients

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Prostate cancer immunotherapy vaccine hits clinical trials

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in